The PBMs say out-of-pocket insulin costs have fallen sharply since 2019. The Pharmaceutical Care Management Association, ...
FTC files lawsuit against top PBMs and GPOs for alleged anticompetitive practices in inflating insulin prices. Learn about the allegations and responses.
Ted Okon, MBA, executive director of the Community Oncology Alliance, spoke with The American Journal of Managed Care® about how the Federal Trade Commission's (FTC) lawsuit against pharmacy benefit ...
The government’s antitrust watchdog on Friday sued three massive health conglomerates, accusing their drug middlemen of ...
The Federal Trade Commission (FTC) has sued the top three pharmacy benefit managers (PBMs) in the US for operating a ...
The Federal Trade Commission is suing the titans of the pharmacy benefit ... “As the complaint explains, the PBMs ...
The U.S. Federal Trade Commission sued the country's three largest pharmacy ... said in a statement that the three ...
Millions of Americans with diabetes need insulin to survive, yet for many of these vulnerable patients, their insulin drug ...
Three companies that process about 80% of prescriptions in the United States — Caremark, Express Scripts and OptumRx — have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback